Full-service CRO focused on clinical development and regulatory strategy,with particular depth in oncology,CNS,and rare disease programs spanning Phase I through post-approval studies.
Vendor description
Best suited for sponsors that need full-service cro support across global programmes.
Sponsors seeking clinical development,regulatory consulting.
- Clinical development,regulatory consulting
- Coverage listed as Global
- Therapeutic/service focus includes Oncology,Rare Disease
- Controlled prototype-to-canonical import only; scoring and deeper evidence enrichment still pending.
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Review snapshot
I did not locate a strong public employee-review footprint for Biorasi in this pass. That is common for smaller or more specialized specialist cro vendors,where staff commentary is often sparse on major public review platforms. Treat the absence of reviews cautiously and place more weight on direct references,case studies,and platform-native reviews once collected.
No consistent public positive themes located
No consistent public negative themes located
Insufficient public evidence
Pricing
$
Key facts
| HQ country | USA |
|---|---|
| Geography | Global |
| Service model | Full Service CRO |
| Customer segment | mixed |
| Study phases | Mixed |
| Trial scale | Specialist and mid-size global programmes |
| Therapeutic areas | Oncology, Rare Disease |
| Last reviewed | 2026-03-28 |
Related vendors
Editorial ranking
See how Biorasi compares - best Full-service CRO vendors for clinical trials.